Renata PLC (DSE:RENATA)

Market Cap	56.69B
Revenue (ttm)	41.39B
Net Income (ttm)	2.81B
Shares Out	114.70M
EPS (ttm)	24.53
PE Ratio	20.15
Forward PE	22.67
Dividend	9.20 (1.86%)
Ex-Dividend Date	Oct 22, 2024

Volume	42,247
Average Volume	110,671
Open	494.50
Previous Close	490.30
Day's Range	490.20 - 496.20
52-Week Range	470.10 - 825.00
Beta	-0.03
RSI	42.35
Earnings Date	Oct 9, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,859
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.